Long-term cardiovascular risk of white-coat hypertension with normal night-time blood pressure values

被引:7
|
作者
Faria, Joao [1 ]
Mesquita-Bastos, Jose [2 ]
Bertoquini, Susana [3 ]
Silva, Jose [3 ]
Barbosa, Loide [3 ]
Polonia, Jorge [1 ]
机构
[1] Univ Porto, Fac Med, Dept Med & Cintesis, Porto, Portugal
[2] Aveiro Univ, Hlth Sch, Aveiro, Portugal
[3] ULS, Hosp Pedro Hispano, Hypertens Unit, Matosinhos, Portugal
关键词
cardiovascular events; normal night-time blood pressure; white-coat hypertension; MASKED HYPERTENSION; COST-EFFECTIVENESS; PROGNOSTIC VALUE; PRIMARY-CARE; EVENTS; STROKE; PREVALENCE; DISEASES;
D O I
10.1097/MBP.0000000000000364
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background The prognostic impact of white-coat hypertension (WCHT) is still a matter of debate and controversy. Night-time blood pressure (NBP) is related strongly to cardiovascular (CV) prognosis, but this has not been considered currently in the definition of WCHT. Patients and methods We investigated the long-term CV prognosis of 2659 patients submitted at admission to 24 h-ambulatory blood pressure (BP) monitoring divided into three groups: normotension (NT) (n=812; 59% female; ageing 49 +/- 13 years), sustained hypertension (SHT) (n=1230; 56% female; ageing 51 +/- 13 years) and WCHT (n=617; 55% female; ageing 50 +/- 3 years) defined as office BP of at least 140/90 mmHg, daytime BP less than 135/85 mmHg and NBP less than 120/70 mmHg. Results The median follow-up was 7.6 years (range: 0.4-24.4), during which a total of 257 CV events (36 fatal) occurred (46% strokes, 32% coronary and 22% others), 38 in NT, 31 in WCHT and 188 in SHT. The event rate per 100 patient-years was 0.60 in the WCHT group, 0.66 in the NT group and 2.09 in the SHT group. Cox's regression analysis adjusted for covariables showed a higher risk of CV events in patients with SHT than WCHT [hazard ratio (HR)=2.230, 95% confidence interval: 1.339-3.716, P=0.002], whereas there was no difference between WCHT and NT groups. Event-free survival was significantly different from SH versus WCHT and NT groups. Within the group of WCHT, 29% of patients received sustained antihypertensive medication during the follow-up, but the HR of CV events between WCHT either treated or not treated did not differ: HR=0.76 (95% confidence interval: 0.37-1.51, P=0.42). Conclusion In patients with WCHT defined by normal daytime and NBP values, the risk of CV events was significantly lower than that of SHT and similar to that of NT patients, suggesting that NBP should be included in the WCHT definition and in its prognostic stratification.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 50 条
  • [21] White-coat hypertension is a risk factor for cardiovascular diseases and totalmortality
    Huang, Yuli
    Huang, Weijun
    Mai, Weiyi
    Cai, Xiaoyan
    An, Dongqi
    Liu, Zhuheng
    Huang, He
    Zeng, Jianping
    Hu, Yunzhao
    Xu, Dingli
    JOURNAL OF HYPERTENSION, 2017, 35 (04) : 677 - 688
  • [22] REPLY: Is White-Coat Hypertension Associated With Risk of Cardiovascular Diseases?
    Franklin, Stanley S.
    Thijs, Lutgarde
    Staessen, Jan A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (23) : 2880 - 2881
  • [23] Is white-coat hypertension associated with increased cardiovascular and mortality risk?
    Muntner, Paul
    Booth, John N., III
    Shimbo, Daichi
    Schwartz, Joseph E.
    JOURNAL OF HYPERTENSION, 2016, 34 (08) : 1655 - 1658
  • [24] Nocturnal blood pressure: the dark side of white-coat hypertension
    Cuspidi, Cesare
    Paoletti, Federico
    Tadic, Marijana
    Sala, Carla
    Gherbesi, Elisa
    Dell'Oro, Raffaella
    Grassi, Guido
    Mancia, Giuseppe
    JOURNAL OF HYPERTENSION, 2020, 38 (12) : 2404 - 2408
  • [25] Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension
    Mancia, Giuseppe
    Bombelli, Michele
    Facchetti, Rita
    Madotto, Fabiana
    Quarti-Trevano, Fosca
    Grassi, Guido
    Sega, Roberto
    JOURNAL OF HYPERTENSION, 2009, 27 (08) : 1672 - 1678
  • [26] WHITE-COAT HYPERTENSION AS PREDICTOR OF LONG-TERM NORMOTENSION IN SUBJECTS SCREENED FOR STAGE 1 HYPERTENSION
    Palatini, P.
    Benetti, E.
    Fania, C.
    Mos, L.
    Mazzer, A.
    Cozzio, S.
    Zanata, G.
    Vriz, O.
    Dorigatti, F.
    Casiglia, E.
    Saladini, F.
    JOURNAL OF HYPERTENSION, 2015, 33 : E73 - E73
  • [27] The long-term reproducibility of the white-coat effect on blood pressure as a continuous variable from the Ohasama Study
    Satoh, Michihiro
    Yoshida, Tomoya
    Metoki, Hirohito
    Murakami, Takahisa
    Tatsumi, Yukako
    Hirose, Takuo
    Takabatake, Kyosuke
    Tsubota-Utsugi, Megumi
    Hara, Azusa
    Nomura, Kyoko
    Asayama, Kei
    Kikuya, Masahiro
    Hozawa, Atsushi
    Imai, Yutaka
    Ohkubo, Takayoshi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [28] The long-term reproducibility of the white-coat effect on blood pressure as a continuous variable from the Ohasama Study
    Michihiro Satoh
    Tomoya Yoshida
    Hirohito Metoki
    Takahisa Murakami
    Yukako Tatsumi
    Takuo Hirose
    Kyosuke Takabatake
    Megumi Tsubota-Utsugi
    Azusa Hara
    Kyoko Nomura
    Kei Asayama
    Masahiro Kikuya
    Atsushi Hozawa
    Yutaka Imai
    Takayoshi Ohkubo
    Scientific Reports, 13
  • [29] Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk
    Hermida, Ramon C.
    Crespo, Juan J.
    Otero, Alfonso
    Dominguez-Sardina, Manuel
    Moya, Ana
    Rios, Maria T.
    Castineira, Maria C.
    Callejas, Pedro A.
    Pousa, Lorenzo
    Sineiro, Elvira
    Salgado, Jose L.
    Duran, Carmen
    Sanchez, Juan J.
    Fernandez, Jose R.
    Mojon, Artemio
    Ayala, Diana E.
    EUROPEAN HEART JOURNAL, 2019, 40 (09) : 789 - 789
  • [30] Cardiovascular Risk Associated With White-Coat Hypertension Pro Side of the Argument
    Mancia, Giuseppe
    Bombelli, Michele
    Cuspidi, Cesare
    Facchetti, Rita
    Grassi, Guido
    HYPERTENSION, 2017, 70 (04) : 668 - 675